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Abstract
Background: Hypertonic saline and mannitol are commonly used in the treatment of cerebral edema and
elevated intracranial pressure (ICP) at present. In this connection, 10% hypertonic saline (HS) alleviates cerebral
edema more effectively than the equal volume of 20% mannitol. However, the exact underlying mechanism for
this remains obscure. This study aimed to explore the possible mechanism whereby 10% hypertonic saline can
ameliorate cerebral edema more effectively than mannitol.
Results: Adult male Sprague-Dawley (SD) rats were subjected to permanent right-sided middle cerebral artery
occlusion (MCAO) and treated with a continuous intravenous infusion of 10% HS, 20% mannitol or D-[1-
3H(N)]-
mannitol. Brain water content (BWC) as analyzed by wet-to-dry ratios in the ischemic hemisphere of SD rats
decreased more significantly after 10% HS treatment compared with 20% mannitol. Concentration of serum Na
+
and plasma crystal osmotic pressure of the 10% HS group at 2, 6, 12 and 18 h following permanent MCAO
increased significantly when compared with 20% mannitol treated group. Moreover, there was negative correlation
between the BWC of the ipsilateral ischemic hemisphere and concentration of serum Na
+, plasma crystal osmotic
pressure and difference value of concentration of serum Na
+ and concentration of brain Na
+ in ipsilateral ischemic
hemisphere in the 10% HS group at the various time points after MCAO. A remarkable finding was the progressive
accumulation of mannitol in the ischemic brain tissue.
Conclusions: We conclude that 10% HS is more effective in alleviating cerebral edema than the equal volume of
20% mannitol. This is because 10% HS contributes to establish a higher osmotic gradient across BBB and,
furthermore, the progressive accumulation of mannitol in the ischemic brain tissue counteracts its therapeutic
efficacy on cerebral edema.
Background
Cerebral edema is involved in many neurological dis-
eases such as cerebral ischemia/hemorrhage, brain
trauma and brain tumor or abscess [1]. Severe cerebral
edema must be managed immediately to prevent brain
herniation. Osmotic therapy is a cornerstone in nonsur-
gical management of intracranial pressure (ICP) induced
by various cerebral edema. Its effectiveness depends on:
1) the integrity of the blood-brain barrier (BBB), 2) the
reflection coefficient of the osmotic agent, and 3) the
osmotic gradient created [2]. 20% mannitol, as a classi-
cal osmotic dehydrating agent, is widely used as a dehy-
drating agent in clinical patients with cerebral edema.
However, because it may lead to hypovolemia, renal dys-
function [3,4], heart failure, electrolyte disturbance and
other side effects, there are certain restrictions in clinical
practice. In recent years, many studies have shown that
1 0 %h y p e r t o n i cs a l i n e( H S )m a yb ee f f e c t i v ei nt r e a t -
ment of all kinds of cerebral edema and intracranial
hypertension caused by various causes, including
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arachnoid hemorrhage [11], brain tumors [12], etc.
Compared with mannitol, HS is more effective to ame-
liorate cerebral edema and intracranial hypertension
[6-8,10,13-16]. Furthermore, HS remains significantly
effective even in situations when use of mannitol had
failed [10] or cerebral hernia [17]. However, the specific
mechanism by which HS can ameliorate cerebral edema
more effectively than equal volume of 20% mannitol
remains unclear. This study sought to determine if 10%
HS administration could decrease cerebral edema more
effectively than 20% mannitol, and if so, whether the
efficacy would be associated with a formation of Na
+
osmotic concentration gradient between blood and
brain tissue. Additionally, we also investigated whether
20% mannitol could accumulate progressively in the
ischemic cerebral tissue. We report here that 10% HS
decreases brain water content (BWC) more effectively
than equal volume of 20% mannitol. The results suggest
that this may be attributed to a formation of Na
+ osmo-
tic concentration gradient between blood and brain tis-
s u eb yH Sa n dp r o g r e s s i v ea c c u m u l a t i o no f2 0 %
mannitol in the ischemic brain tissue.
Methods
Animals and experimental groups
Adult male Sprague-Dawley (SD) rats 250-300 g (body
weight) (Experimental Animal Center of SUN YAN-SEN
University, China) were randomly divided into a sham-
operated group (n = 48), cerebral ischemic + normal sal-
ine treatment group (abbreviated: normal saline group)
(n = 48), cerebral ischemic + 20% mannitol treatment
group (abbreviated: 20% mannitol group) (n = 60), and
cerebral ischemic + 10% HS treatment group (abbre-
viated: 10% HS group) (n = 48). Under aseptic surgical
conditions, the tail vein was cannulated to facilitate the
intravenous (i.v.) infusion of 20% mannitol, 10% HS or
normal saline. Rats in normal saline group, 20% mannitol
group and 10% HS group were subjected to permanent
right-sided middle cerebral artery occlusion (MCAO). In
the sham-operated group, the rats were anesthetized with
5% Ketamine (FuJian GuTian Pharmaceutical Co., Ltd.,
China) following which the right common carotid artery
(CCA) was exposed but not subjected to MCAO. At 6 h
following MCAO, the rats in sham-operated group and
normal saline group were treated with normal saline (0.3
ml/h). At the same time point, the rats in 20% mannitol
group and 10% HS group were treated with a continuous
intravenous infusion (0.3 ml/h) of 20% mannitol or 10%
HS, respectively, via the tail vein until the end of the
experiment. The rats in sham-operated group, normal
saline group, 20% mannitol group and 10% HS treatment
group were further subdivided into four subgroups
according to different treatment times: 2, 6, 12 and 18 h.
In addition, 12 of the rats in 20% mannitol group were
also subdivided correspondingly into four subgroups: 2,
6, 12 and 18 h following the onset of treatment with 20%
D-[1-
3H(N)]-mannitol (NET101005MC., PerkinElmer,
Inc. USA). In this connection, the rats were treated with
a continuous intravenous infusion (50 μCi/h) of D-[1-
3H
(N)]-mannitol via the tail vein until the end of the experi-
ment. The number of rats killed at various time points in
different groups is shown in Table 1. Animal handling
and experiments were approved by Institutional Animal
Care and Use Committee, Guangdong Province, China.
Focal brain ischemia animal model
In rats subjected to MCAO, they were fasted overnight
prior to surgery, but were allowed free access to water.
The rats were anesthetized with 5% Ketamine (40 mg/
kg). Rectal temperature was maintained between 37 and
37.5°C with a heating lamp throughout the surgical pro-
cedures. Focal brain ischemia was induced by the intra-
luminal suture MCAO method as described previously
[18,19,13]. Briefly, the right CCA, internal carotid artery
(ICA), and external carotid artery (ECA) were exposed
through a midline incision of the neck. A 4-0 headend
spherical nylon suture was used as an occluder and was
inserted via the CCA. For the CCA occlusion route, the
proximal portions of the right CCA and ECA were
ligated with 5-0 surgical sutures, and the occluder was
inserted through an arteriotomy of the right CCA 3 mm
below the carotid bifurcation. The occluder was advanced
into the ICA 17 to 19 mm beyond the carotid bifurcation.
Mild resistance indicated that the occluder was properly
lodged in the middle cerebral artery (MCA) and thus
blocked the blood flow to the artery. Sham-operated rats
were subjected to the surgical procedures except for
MCAO. Neurologic examinations were performed 6 h
after the onset of occlusion. The neurologic findings
were scored on a five-point scale [18]: 0, no neurologic
deficit; 1, a mild focal neurologic deficit (failure to extend
left forepaw fully); 2, a moderate focal neurologic deficit
(circling to the left); and 3, a severe focal deficit (falling
to the left); 4, no spontaneous motor activity (the rats did
not walk spontaneously and had a depressed level of con-
sciousness). The rats with neurologic deficit score of 1 to
3 were considered as an effective model.
Assessment of ischemic hemispheric brain edema
Rats were killed at the end of the experiment by decapi-
tation under deep anesthesia. The brain was quickly
removed and gently blotted to remove small quantities
of adsorbent moisture and were dissected through the
interhemispheric fissure into ipsilateral ischemic and
contralateral hemispheres. Brain edema was estimated
by comparing wet to dry weight ratios [20,21]. Tissues
were weighed with a scale to within 0.001 mg. Dry
Zeng et al. BMC Neuroscience 2010, 11:153
http://www.biomedcentral.com/1471-2202/11/153
Page 2 of 10w e i g h to ft h ee n t i r ei s c h e m i ch e m i s p h e r e sw a sd e t e r -
mined after heating the tissue for 3 days at 100°C in a
drying oven. Tissue water content was then calculated
as % H2O = (1-dry wt/wet wt) × 100% [20,21].
Assessment of concentration of brain Na
+ of ischemic
hemisphere, serum Na
+ and plasma crystal osmotic
pressure
Brain tissue was removed as described above. Normal
saline at 2 ml/g ischemic hemisphere brain tissue was
then added. The tissue was homogenated by power-dri-
ven in the ice, followed by centrifugation at 12,000 rev/
min for 5 min. Finally, concentration of brain Na
+ of
ischemic hemisphere was detected by automatic bio-
chemical analyzer (UniCel DxC 800 Synchron, Beckman
Coulter, Inc., USA) in 500 μL supernatant. In addition,
Four mL blood samples were drawn from rats under
deep anesthesia. The blood samples were then centri-
fuged (3,000 rev/min for 5 min) after standing 2 h. The
concentration of serum Na
+ and plasma crystal osmotic
pressure were detected by an automatic biochemical
analyzer (UniCel DxC 800 Synchron, Beckman Coulter,
Inc., USA) with 500 μL supernatant.
Assessment of the non-ischemic and ischemic hemisphere
D-[1-
3H(N)]-mannitol content by autoradiography and
liquid scintillation method
Method for autoradiography
Rats were killed at the end of the experiment by
decapitation under deep anesthesia. They were
perfused transcardially with saline and the brain
removed immediately. Coronal frozen sections of the
brain of 30 μm thickness at the level of the optic
chiasma were cut and fixed for 30 sec with anhydrous
methanol. Brain sections were immersed in nuclear
emulsion N-4 (Fujifilm Corporation, Japan) for 30 sec
and then exposed for four weeks in the darkroom.
Subsequently the sections were developed, fixed and
fully dried. The number of silver grains of the peri-
infarct brain tissue and the corresponding non-
ischemic brain tissue was calculated by counting six
randomly selected microscopic fields in sections
obtained from each rat (n = 3) at × 20 objective by a
blinded observer.
Liquid scintillation method
Fifty mg of the peri-infarction brain tissue as well as the
corresponding non-ischemic brain tissue at the level of
the optic chiasma level was quickly removed. Two hun-
dred μL perchloric acid and 200 μL 30% hydrogen per-
oxide were added successively in the brain tissue. The
specimen was reacted in the 80°C incubator for 30 min
resulting in a homogeneous liquid. After the liquid was
cooled to room temperature, 200 μL of the liquid was
transferred to special bottles for liquid scintillation. In
the latter, 2 mL scintillation fluid and 2 mL ethanol
were added, respectively. The reaction mixture was sha-
ken for a few sec turning it into a clear liquid. The con-
centration of the D-[1-
3H(N)]-mannitol was then
detected by liquid scintillation analyzer (Tri-Carb
2900TR, PerkinElmer, Inc. USA).
Table 1 Number of rats killed at various time points in different groups
Groups BWC Concentration of brain Na
+ Blood parameters Autoradiography and concentration of D-[1-
3H(N)]-mannitol
Sham-operated group
2h 6 6 8 0
6h 6 6 8 0
12 h 6 6 8 0
18 h 6 6 8 0
Normal saline group
2h 6 6 8 0
6h 6 6 8 0
12 h 6 6 8 0
18 h 6 6 8 0
20% mannitol group
2h 6 6 8 3
6h 6 6 8 3
12 h 6 6 8 3
18 h 6 6 8 3
10% HS group
2h 6 6 8 0
6h 6 6 8 0
12 h 6 6 8 0
18 h 6 6 8 0
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All data were analyzed using the SPSS13.0 statistical
software. Different statistical methods were applied
according to types of data. Values were expressed as
mean ± standard deviation (± SD). Univariate-factor
measurement data was analyzed by one-way ANOVA,
but two-factor measurement data was analyzed by two-
way classification ANOVA. Multiple comparisons were
analyzed by LSD method if the data was homogeneity of
variance, otherwise they were analyzed by Dunnett’sT 3
method. Bivariate correlation analysis of measurement
data was analyzed by Pearson correlation analysis. The
difference was considered statistical significance when
P < 0.05.
Results
Ipsilateral ischemic hemispheric BWC
Analysis of ischemic hemispheric brain edema revealed
that BWC in the ipsilateral ischemic hemispheres of the
normal saline group, the 20% mannitol group and the
10% HS group at 2, 6, 12 and18 h following permanent
MCAO increased significantly when compared with that
in the sham operated group (*
#※&P < 0.05) (Figure 1).
Compared with the normal saline group, BWC in the
Figure 1 Ipsilateral ischemic hemispheric BWC. BWC(%) in the ipsilateral ischemic hemisphere of the normal saline group, 20% mannitol
group and 10% HS group at 2, 6, 12 and 18 h following permanent MCAO and the corresponding sham operated group. Bar graph shows that
the percentage of BWC is significantly increased in the ipsilateral ischemic hemisphere of the normal saline group, 20% mannitol group and 10%
HS group at various time points when compared with the sham operated group (*
#&P < 0.05). The percentage of BWC decreases significantly in
the ipsilateral ischemic hemisphere at 2, 6 and 12 h following treatment with 20% mannitol or 10% HS compared with the normal saline group
(
#P < 0.05,
※P < 0.05). At 18 h, compared with the normal saline group, the percentage of BWC in the 20% mannitol does not decrease
significantly (
&P > 0.05). However, the BWC of 10% HS group continues to decrease significantly (
※P < 0.05). BWC in the ipsilateral ischemic
hemispheres of the 10% HS group at 2, 6, 12 and18 h decreases significantly when compared with the 20% mannitol group(
※P < 0.001).
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group and the 10% HS group at 2, 6 and12 h decreased
significantly (
#※P <0 . 0 5 ) .A t1 8h ,h o w e v e r ,t h eB W C
of 20% mannitol group was not significantly different in
comparison with the normal saline group (
&P = 0.551).
On the other hand, the BWC of 10% HS group contin-
ued to decrease and was significantly different from the
normal saline group (
※P < 0.001). BWC in the ipsilat-
eral ischemic hemispheres of the 10% HS group at 2, 6,
12 and18 h decreased significantly when compared with
the 20% mannitol group (
※P < 0.001) (Figure 1).
Concentration of brain Na
+ of ischemic hemisphere,
serum Na
+ and plasma crystal osmotic pressure
Analysis of concentration of brain Na
+ of ischemic
hemisphere revealed that in the normal saline group,
20% mannitol group and the 10% HS group at 2, 6, 12
and 18 h following permanent MCAO, it was increased
significantly when compared with that in the sham
operated group (
#P < 0.001) (Figure 2A). The concentra-
tion of brain Na
+ in the 10% HS was not increased sig-
nificantly when compared with that of the normal saline
group and 20% mannitol group (*P > 0.05) (Figure 2A).
Analysis of concentration of serum Na
+ revealed that in
the 10% HS group at 2, 6, 12 and18 h following perma-
nent MCAO, it was increased significantly when com-
pared with that in the sham operated group, the normal
saline group and the 20% mannitol group (
#P <0 . 0 0 1 )
(Figure 2B). The concentration of serum Na
+ in the 10%
HS was not significantly different between the various
time points (F = 0.381, P = 0.767) (Figure 2B). Analysis
of plasma crystal osmotic pressure revealed that in the
10% HS group at 2, 6, 12 and18 h following permanent
MCAO, it was increased significantly when compared
with that in the sham operated group, the normal saline
group and the 20% mannitol group (
#P <0 . 0 1 )( F i g u r e
2C). The plasma crystal osmotic pressure in the 10% HS
did not differ significantly between various time points
(F =0 . 3 4 1 ,P = 0.796) (Figure 2C). Furthermore, addi-
tional analysis of the difference value in concentration
of serum Na
+ and Na
+ in ipsilateral ischemic hemi-
sphere revealed that in the 10% HS group at 2, 6, 12
and 18 h following permanent MCAO, it was increased
significantly when compared with the normal saline
group and the 20% mannitol group(
#P <0 . 0 5 )( F i g u r e
2D). Compared with the sham operated group, the dif-
ference value of concentration of serum Na
+ and brain
Na
+ in ipsilateral ischemic hemisphere of the 10% HS
g r o u pa t2 ,6 ,1 2a n d1 8hf o l l o w i n gp e r m a n e n tM C A O
was not significantly different (
#P > 0.05). Moreover,
there was no difference between the normal saline
group and the 20% mannitol group at 2, 6, 12 and 18 h
following permanent MCAO (
&P > 0.05) (Figure 2D). At
the same time, Correlation analysis revealed that there
was negative correlation between the BWC of the ipsi-
lateral ischemic hemisphere and concentration of serum
Na
+ (r = -0.811, -0.865, -0.863, -0.911, respectively; All
P < 0.05) and plasma crystal osmotic pressure (r =
-0.813, -0.888, -0.887, -0.915, respectively; All P < 0.05)
in the 10% HS group at 2, 6, 12 and 18 h following per-
manent MCAO.
Autoradiography
Analysis of autoradiography revealed that the number
and distribution of dark silver particles in autoradiogra-
phy may reflect indirectly the content and distribution
of D-[1-
3H(N)]-mannitol. Dark silver particles were
sparsely distributed in the peri-infarction brain tissue at
2 h following administration with D-[1-
3H(N)]-mannitol
(Figure 3E). The silver grains appeared to increase in
number from 6 to 18 h (Figure 3F, G, H). Compared
with 2 h, the dark silver particles were more numerous
at 12 and 18 h (Figure 3G, H) suggesting that mannitol
was progressively accumulated in the ipsilateral infarcted
region. Likewise, the incidence of the silver particles
increased continuously in the corresponding non-
ischemic brain tissue from 2 to 18 h (Figure 3A, B, C,
D), notably at 12 and 18 h (Figure 3C, D). Results of
actual particle count showed that the number of dark
silver particles in the pre-infarction brain tissue and the
corresponding areas in the non-ischaemic tissue
increased from 2 to 18 h after administration with D-[1-
3H(N)]-mannitol (P <0 . 0 1 ) .T h en u m b e ro ft h es i l v e r
particles in the non-ischemic brain tissue was less than
that in the ischemic brain tissue at 6, 12 and 18 h (*P <
0.01) (Figure 3I).
Concentration of D-[1-
3H(N)]-mannitol in the peri-
infarction brain tissue and corresponding non-ischemic
brain tissue
Analysis of liquid scintillation method revealed that the
concentration of D-[1-
3H(N)]-mannitol in the peri-
infarction brain tissue increased progressively from 2 to
18 h after administration with D-[1-
3H(N)]-mannitol. It
increased notably at 18 h in comparison with that at 2,
6a n d1 2h(
&P < 0.001) (Figure 4). This indicates that
mannitol continued to accumulate in the ipsilateral
infarcted region. The concentration of D-[1-
3H(N)]-
mannitol was also progressively increased in the corre-
sponding non-ischemic hemisphere brain tissue from 2
to 18 h. Compared with 2 h, the concentration of D-[1-
3H(N)]-mannitol did not increase significantly at 6 h in
the peri-infarction brain tissue and corresponding non-
ischemic brain tissue (P = 0.064) (Figure 4). However,
increase at 12 and 18 h in comparison with 6 h was sig-
nificant (
§P < 0.001) (Figure 4). The concentration of D-
[1-
3H(N)]-mannitol in the peri-infarction brain tissue
increased significantly at 12 and 18 h when compared
Zeng et al. BMC Neuroscience 2010, 11:153
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sue (*P < 0.05) (Figure 4).
Discussion
HS alleviates cerebral edema and lowers ICP by estab-
lishing an osmotic gradient between the intracellular
and intravascular space [22]. It has been widely used for
the treatment of cerebral edema and elevated intracra-
nial pressure (ICP) resulting from cerebral infarction
[13,23], hemorrhage [24] or traumatic brain injury
[25,26]. Studies have shown that when compared with
equal volume of mannitol, HS solutions may be more
effective in lowering elevated ICP [27]. HS at 7.5%
showed a higher increase in serum osmolality at 15 min
after administration than 20% mannitol [28]. But, cere-
brospinal fluid, mean arterial pressure and central
venous pressure were not different between the 7.5% HS
and 20% mannitol treatment [28]. In both pediatric and
adult traumatic brain injury (TBI), HS has been used
effectively to reduce elevated ICP which is refractory to
mannitol administration [25,26]. This study has shown
that BWC in the ipsilateral ischemic hemispheres of the
20% mannitol group and the 10% HS group at 2, 6 and
12 h following permanent MCAO decreased signifi-
cantly when compared with that in the normal saline
group. However, when compared with BWC of the nor-
mal saline group at 18 h, the BWC of 20% mannitol
group was not reduced, but the BWC of 10% HS group
was decreased significantly. BWC in the ipsilateral
ischemic hemispheres of the 10% HS group at 2, 6, 12
and18 h decreased significantly when compared with the
20% mannitol group. BWC can reflect the degree of
Figure 2 Plasma crystal osmotic pressure, brain Na
+ concentration, serum Na
+ concentration and difference value of both.N a
+
concentration of the ipsilateral ischemic hemispheres (A), serum Na
+ concentration (B), plasma crystal osmotic pressure (C) and difference value
in concentration of serum Na
+ and concentration of brain Na
+ in ipsilateral ischemic hemisphere (D) of the normal saline group, the 20%
mannitol group and 10% HS group at 2, 6, 12 and18 h following permanent MCAO as well as matching sham operated group
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shows the number of black silver particles in the peri-infarction brain tissue. The number of black silver particles increases from 2 to 18 h after
administration with D-[1-
3H(N)]-mannitol (E, F, G, H) in comparison with the corresponding areas in the non-ischemic tissue (A, B, C, D) being
more marked at 12 and 18 h (G, H). The number of dark silver particles also increases in the non-ischemic brain tissue from 2 to 18 h (A, B, C,
D), notably at 12 and 18 h (C, D), but the number of particles is evidently less than that in the ischemic brain tissue at corresponding time
points. Figure 3I shows a significant increase in the black silver particles in the peri-infarction brain tissue at 6, 12 and 18 h following permanent
MCAO. Scale bars: A-H, 20 μm.
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that 10% HS is more effective in treatment of cerebral
edema when compared with the 20% mannitol.
Na
+ ions increased commonly in the cerebral edema
region, with a concomitant decrease in K
+ ions [31,32].
The increase in Na
+ i o n sm a yb ea t t r i b u t e dt or e d u c e d
brain tissue spaces resulted from cerebral edema and,
furthermore, the Na
+ ions are not reabsorbed because of
obstruction of CSF reflux [32]. In addition, the activa-
tion of corresponding ion channels such as NKCC1
plays an important role in increasing the concentration
of Na
+ ions in ischemic cerebral tissue [33-35]. Another
possible explanation would be that Na
+ ions enter the
cerebral parenchyma via increased BBB permeability
caused by BBB breakdown. This study has shown that
the concentration of Na
+ ions in ipsilateral ischemic
hemisphere in the normal saline group, 10% HS group
and 20% mannitol group increases significantly. How-
ever, Na
+ concentration in the 10% HS group was not
significantly different from the normal saline group and
the 20% mannitol group. These results demonstrated
that 10% HS administration did not cause an abnormal
accumulation of Na
+ in the brain tissue. The reason
may be that 10% HS does not aggravate BBB breakdown
[36].
The formula for plasma crystal osmotic pressure is as
follows: plasma crystal osmolality (mosm/L) = 2 [Na
+(mmol/L) + K
+(mmol/L)] + BUN (mmol/L) + Glu
(mmol/L). It is suggested from the formula that Na
+
ions play an important role in the maintenance of
plasma crystal osmotic pressure. In this connection, if
the concentration of serum Na
+ increases, the plasma
crystal osmotic pressure will be inevitably increased. In
addition, the Na
+ ions have been reported to play a
major role in the maintenance of homeostasis and
osmotic pressure balance inside and outside cells
[37,38]. The same is true in the brain in which Na
+ ions
imbalances are bound to lead to the osmotic pressure
imbalance inside and outside cells and the cerebrovascu-
lar system [39]. Therefore, the difference value of con-
centration of serum Na
+ and concentration of brain Na
+
reflect indirectly the osmotic pressure gradient inside
and outside the BBB. The present results have shown
that the concentration of serum Na
+ or plasma crystal
osmotic pressure in the 10% HS group at 2, 6, 12 and
18 h increased significantly when compared with that in
the other groups. Moreover, compared with other
groups, the difference value of concentration of serum
Na
+ and concentration of brain Na
+ in ipsilateral
ischemic hemisphere in 10% HS group was increased
significantly. Further analysis showed that not only there
was negative correlation between the BWC of the ipsi-
lateral ischemic hemisphere and concentration of serum
Na
+ or plasma crystal osmotic pressure, but also there
was negative correlation between the BWC of the
ischemic hemisphere and the difference value of concen-
tration of serum Na
+ and concentration of brain Na
+ in
ipsilateral ischemic hemisphere in the 10% HS group at
2, 6, 12 and 18 h following permanent MCAO. There-
fore, it is speculated that one of the reasons that 10%
HS can ameliorate the cerebral edema more effectively
than 20% mannitol may be because it can maintain a
higher osmotic pressure gradient inside and outside the
BBB.
This study has also shown that D-[1-
3 H (N)]-manni-
tol tends to accumulate in the ischemic cerebral hemi-
sphere and the non-ischemic cerebral hemisphere, being
most pronounced at 18 h. It is noteworthy that the
effect of 20% mannitol in ameliorating the cerebral
edema was weakened significantly at 18 h. A possible
explanation for this would be that mannitol leaks
through the disrupted BBB continuously and accumu-
lates in the brain parenchyma, so that the osmotic pres-
sure gradient inside and outside of the BBB is decreased
or even reversed. This would weaken its effect in ameli-
orating the cerebral edema and may even aggravate the
latter. Kaufmann and Cardoso [40] and Cho et al [41]
reported that mannitol accumulated constantly in the
injured cerebral hemisphere when it was used repeatedly
by the intravenous route, so that the osmotic pressure
gradient inside and outside the BBB is reversed, thus
exacerbating the cerebral edema. The reason that man-
nitol accumulates in the non-ischemic brain tissue may
be related to increase of BBB permeability resulting
from a variety of inflammatory mediators induced by
Figure 4 Concentrations of D-[1-
3H(N)]-mannitol in the
ischemic and non-ischemic brain tissue. Concentrations of D-[1-
3H(N)]-mannitol in the ischemic and non-ischemic brain tissue at 6,
12 and 18 h following permanent MCAO. Note the progressive
increase in concentration of D-[1-
3H(N)]-mannitol in the peri-
infarction brain tissue continuously from 2 to 18 h after
administration with D-[1-
3H(N)]-mannitol as detected by liquid
scintillation analyzer.
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ing of BBB by itself [44]. In an experimental animal
study, it was reported that not only BBB breakdown, but
also BWC of ipsilateral hemisphere increased signifi-
cantly after healthy adult female Wistar rats were
injected with mannitol via the left jugular vein [44]. A
possible mechanism related to this may be shrinkage of
vascular endothelial cells and opening of endothelial
tight junctions by mannitol [45,46]. Undoubtedly, abnor-
mal accumulation of 20% mannitol in the pre-ischemic
cerebral hemisphere and the non-ischemic cerebral
hemisphere offset an osmotic pressure gradient inside
and outside the BBB induced by mannitol. These also
help to explain the facts that mannitol is less effective to
ameliorate cerebral edema and intracranial hypertension
when compared with HS.
Conclusions
This study has shown that 10% HS is more effective in
alleviating cerebral edema compared with equal volume
of 20% mannitol. The following are possible mechan-
isms: 1) a higher osmotic pressure gradient is estab-
lished by 10% HS across the BBB; 2) mannitol tends to
accumulate progressively in the brain tissue and more
severely in the ischemic cerebral hemisphere than the
non-ischemic cerebral hemisphere with continuous
intravenous injection of 20% mannitol. Undoubtedly,
this will counteract the therapeutic efficacy of 20% man-
nitol on cerebral edema.
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